C4 Therapeutics (CCCC) EBT Margin Growth (1y) (2020 - 2026)
C4 Therapeutics (CCCC) EBT Margin Growth (1y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-1,532.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,558.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
C4 Therapeutics |
520.69 Mn |
285.02 Mn |
- |
-4,480.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
-4,480.00 |
| Dec 31, 2025 |
48,042.00 |
| Sep 30, 2025 |
-12,586.00 |
| Jun 30, 2025 |
-25,504.00 |
| Mar 31, 2025 |
56,957.00 |
| Dec 31, 2024 |
39,196.00 |
| Sep 30, 2024 |
7,457.00 |
| Jun 30, 2024 |
120,086.00 |
| Mar 31, 2024 |
-799.00 |
| Dec 31, 2023 |
24,566.00 |
| Sep 30, 2023 |
23,804.00 |
| Jun 30, 2023 |
-115,413.00 |
| Mar 31, 2023 |
-51,213.00 |
| Dec 31, 2022 |
-122,492.00 |
| Sep 30, 2022 |
-18,278.00 |
| Jun 30, 2022 |
3,657.00 |
| Mar 31, 2022 |
-13,072.00 |
| Dec 31, 2021 |
18,731.00 |
| Sep 30, 2021 |
-2,992.00 |
| Jun 30, 2021 |
-11,751.00 |
